AB-1005 not checked
AskBio Inc · AAV2-GDNF gene therapy
FollowEvery change as it happens, and a Monday email
Trials
2 active
2 in total · 1 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Bilateral image-guided infusion of AAV2-GDNF into putamen, single dose”In the company’s words, NCT06285643 on ClinicalTrials.gov
- Tested for
- PARKINSON DISEASE (Disorder), Parkinson Disease
- Main trialPhase 2
- “This study is being done to test a new way of delivering AB-1005 into the brain. The goal is to make the procedure easier and quicker to perform, while providing similar amounts of drug to the part of the brain that needs treatment. Technical (Stage 0) To test if the new delivery method (prefrontal surgical approach) can consistently deliver AB-1005 to the putamen using MRI monitoring. Technical (Stage 1) To test if the new delivery method (PIA-based infusion) can consistently deliver AB-1005 to the putamen using brain imaging by MRI. Technical (Stage 2) To confirm the new delivery method…”In the company’s words, NCT07215403 on ClinicalTrials.gov
- Other names
- AAV2-GDNF gene therapy · Biological
Other drugs for PARKINSON DISEASE (Disorder)
- PembrolizumabMerck & Co. · Phase 3
- Sacituzumab govitecanGilead (Kite) · Phase 3
- Intismeran autogeneMerck & Co. · Moderna · Phase 3
- LenvatinibEisai · Merck & Co. · Phase 3
- Sacituzumab tirumotecanKelun-Biotech · Merck & Co. · Phase 3
- BHV-8000Biohaven · Phase 2/3
Coming up2
- 30 Apr 2028Phase 2 trial completes · ClinicalTrials.gov
- 31 Aug 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 30 Apr 2028 | Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA) | |
| Phase 2Active, not recruiting | 31 Aug 2028 | A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026